In vitro basic fibroblast growth factor (bFGF) delivery using an antithrombogenic 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer coated with a micropatterned diamond‐like carbon (DLC) film. Issue 12 (23rd September 2017)
- Record Type:
- Journal Article
- Title:
- In vitro basic fibroblast growth factor (bFGF) delivery using an antithrombogenic 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer coated with a micropatterned diamond‐like carbon (DLC) film. Issue 12 (23rd September 2017)
- Main Title:
- In vitro basic fibroblast growth factor (bFGF) delivery using an antithrombogenic 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer coated with a micropatterned diamond‐like carbon (DLC) film
- Authors:
- Bito, Kenta
Hasebe, Terumitsu
Maegawa, Shunto
Maeda, Tomoki
Matsumoto, Tomohiro
Suzuki, Tetsuya
Hotta, Atsushi - Abstract:
- Abstract: In this study, a newly designed drug‐release platform composed of an antithrombogenic 2‐methacryloyloxyethyl phosphorylcholine (MPC) polymer was introduced, which was impregnated with basic fibroblast growth factor (bFGF) (bFGF/MPC polymer) to enhance the endothelial cell activation. The platform was also coated with an ultrathin micropatterned diamond‐like carbon (DLC) film (DLC/bFGF/MPC polymer) to precisely control the drug release rate and the cell compatibility. The resulting DLC/bFGF/MPC polymer could effectively prolong the bFGF release rate by depositing the micropatterned DLC. The number of adherent platelets on the DLC/bFGF/MPC polymer was significantly lower (about 1/14) than that on a currently used stent made of stainless steel (SUS316L), indicating the enhanced antithrombogenicity in the DLC/bFGF/MPC polymer. The proliferation of endothelial cells on the DLC/bFGF/MPC polymer and the DLC/MPC polymer (without bFGF) were also examined. It was found that the optical density of HUVEC on the DLC/bFGF/MPC polymer determined by WST‐8 assay was higher by 25%than that on the DLC/MPC polymer (without bFGF) measured after 72 h of incubation. Our results suggest that the released bFGF that contributes to the expression of other growth factors results in the early proliferation of the HUVEC on the DLC/bFGF/MPC polymer. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 3384–3391, 2017.
- Is Part Of:
- Journal of biomedical materials research. Volume 105:Issue 12(2017)
- Journal:
- Journal of biomedical materials research
- Issue:
- Volume 105:Issue 12(2017)
- Issue Display:
- Volume 105, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 105
- Issue:
- 12
- Issue Sort Value:
- 2017-0105-0012-0000
- Page Start:
- 3384
- Page End:
- 3391
- Publication Date:
- 2017-09-23
- Subjects:
- DLC -- MPC -- bFGF -- drug release -- biocompatibility
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1552-4965 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jbm.a.36201 ↗
- Languages:
- English
- ISSNs:
- 1549-3296
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4953.720000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5262.xml